Signum Life Science ApS
CVR 36559241 · Private limited company (ApS) · Active · Low risk
Signum Life Science ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry computerkonsulentbistand og forvaltning af computerfaciliteter. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 11 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 40.7m and a net result of DKK -66.0m.
Bankruptcy risk for Signum Life Science ApS
0.4 × the average (1.41%) · higher risk than 59% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36559241
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (11 years)
- Address
- Lersø Parkallé 101
2100 København Ø - Municipality
- København
- Industry
- Computerkonsulentbistand og forvaltning af computerfaciliteter (622000)
Bankruptcies in the industry: Konsulentbistand vedrørende informationsteknologi - Share capital
- DKK 75k
- Employees
- 26 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 11 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 71.8% |
| Current ratio | 250% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -67.4m | DKK -1.9m |
| Net profit | DKK -66.0m | DKK -5.9m |
| Equity | DKK 40.7m | DKK 106.8m |
| Total assets | DKK 56.7m | DKK 125.6m |
| Cash | DKK 5.4m | – |
| Short-term debt | DKK 16.0m | – |
| Tax owed | DKK 0 | – |
| Avg. employees | 43 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 141 | ||
| 1 Jan 2024 – 31 Dec 2024 | 136 | ||
| 1 Jan 2023 – 31 Dec 2023 | 135 | ||
| 1 Jan 2022 – 31 Dec 2022 | 131 | ||
| 1 Jan 2021 – 31 Dec 2021 | 132 | ||
| 1 Jan 2020 – 31 Dec 2020 | 146 | ||
| 1 Jan 2019 – 31 Dec 2019 | 118 | ||
| 1 Jan 2018 – 31 Dec 2018 | 128 | ||
| 1 Jan 2017 – 31 Dec 2017 | 145 | ||
| 1 Jan 2016 – 31 Dec 2016 | 142 | ||
| 1 Jan 2015 – 31 Dec 2015 | 146 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Tore von Würden Petersen | Current | |
| Board | Søren Hvidsten Nielsen | Current | |
| Board | Anne Marie Hedegaard Byskov | Current | |
| Board | Anne Cathrine Falch-Jørgensen | Current | |
| Board | Mari-Ann Retz | Current | |
| Board | Anja Cecilie Verhaug | Current | |
| Board | Thomas Gross Nødvig | ||
| Board | Pia Krogsgaard Villadsen | ||
| Board | Lasse Richter Petersen | ||
| Board | Jan Ulrik Stevnsborg | ||
| Board | Lone Henriette Andreasen | ||
| Board | Allan Karne Levisen | ||
| Board | Christophe Duret | ||
| Board | Thomas Gross Nødvig | ||
| Board | Jan Fritzbøger | ||
| Board | Christophe Duret | ||
| Board | Carina Schaldemose Sørensen | ||
| Board | Mads Tang Dalsgaard | ||
| Board | Anders Thelborg | ||
| Board | Christina Dyreborg Jeppesen | ||
| Board | Henriette Rosenquist | ||
| Board | Julie Enevold Brooker | ||
| Board | Mads Veggerby Lausten | ||
| Board | Thomas Gross Nødvig | ||
| Board | Christina Dyreborg Jeppesen | ||
| Board | Christoffer Dahl | ||
| Board | Thomas Gross Nødvig | ||
| Board | Lars Møller | ||
| Board | Mads Veggerby Lausten | ||
| Board | Andreas Daugaard Jørgensen | ||
| Board | Thomas Bo Bjørn Klee | ||
| Board | Lars Møller | ||
| Board | Allan Karne Levisen | ||
| Board | Cecilie Betzer | ||
| Board | Jonas Emil Steenvinkel | ||
| Board | Allan Karne Levisen | ||
| Board | Thomas Bo Bjørn Klee | ||
| Board | Lars Møller | ||
| Board | Andreas Daugaard Jørgensen | ||
| Board | Tore von Würden Petersen | ||
| Board | Jonas Emil Steenvinkel | ||
| Board | Mari-Ann Retz | ||
| Board | Christian Bruun-Andersen | ||
| Board | Felicia Nina Ida Salicath | ||
| Board | Julie Enevold Brooker | ||
| Board | Anja Cecilie Verhaug | ||
| Board | Johannes Michael Leuchs | ||
| Owner (90%) | DLI - DANSK LÆGEMIDDEL INFORMATION A/S | Current | |
| Owner (10%) | TJELLESEN MAX JENNE A/S | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | DLI - DANSK LÆGEMIDDEL INFORMATION A/S | Current |
Address history (0 moves)
| Lersø Parkallé 101, 2100 København Ø |
Former names
| Signum Life Science ApS | – now |
| DLI Market Intelligence ApS | – |
Employees per year
Other companies at the same address
Similar companies in København
- MAINTECH CONSULT A/S Valby
- Devoteam A/S København V
- PROGRESS SOFTWARE A/S København Ø
- Darize A/S København Ø
- welwio ApS København S
- SII Group Denmark A/S København Ø
- Solvirk ApS København S
- Brun Labrador ApS København NV
- CraftWorks-IT ApS København S
- X-Report ApS København V
- WCKD ApS København S
- Failsafe ApS Vanløse
Questions and answers about Signum Life Science ApS
Has Signum Life Science ApS gone bankrupt?
No, Signum Life Science ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Signum Life Science ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the auditor of Signum Life Science ApS?
Signum Life Science ApS most recently used EY Godkendt Revisionspartnerselskab.
When was Signum Life Science ApS founded?
Signum Life Science ApS was founded on 2 March 2015.
What is the equity of Signum Life Science ApS?
Equity was DKK 40.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.